FDA Investigator Tekalign Wondimu
Tekalign Wondimu has inspections in 2 countries as of 19 Oct 2023. Tekalign Wondimu has collaborated with a combined 1423 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
19 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Canada,
United States of America
Co-Investigator(s):
Albert A Salvador,
Amy N Chen,
Anastasia G Lolas,
Anastasia M Shields,
Anita R Michael,
Anthony A Charity,
Audrey Thereset Uy,
CDR John Mastalski,
Christina K Theodorou,
Craig D Zagata,
Daniel J Min,
Daniel W Johnson,
David A Oluwo,
David J Hafner,
Deborah J Parris,
Debra J Bennett,
Debra L Pagano,
Demitria J Xiradakis,
Denise M Digiulio,
Douglas C Kovacs,
Dr. Gerald E Poly,
Elaine E Gilfillan,
Eric Rothschild,
George Pyramides,
Hala L Selby,
Helen Verdel,
James A Liubicich,
James M Mason,
James P Mcevoy,
Jay T Wong,
Johnna L Bleem,
Jose M Cayuela,
Joseph L Despins, PhD,
Juan Rjimenez Garcia,
Juanita P Versace,
Julianne C Mccullough,
Kames A Liubicich,
Karen A Briggs,
Karyn M Campbell,
Kendra L Brooks,
Kristen D Evans,
Kristina J Donohue,
LCDR Susan E Polifko,
Lisa B Orr,
LT John M Mastalski,
Marcellinus D Dordunoo,
Marcus A Ray,
Martha Sullivan Myrick,
Matthew R Noonan,
Meredith L Sheridan,
Michael A Taylor,
Michael D Omeara,
Michael L Casner,
Michael R Klapal,
Mindy M Chou,
Nancy F Scheraga,
Nikisha M Bolden,
Paul L Bellamy,
Philip F Istafanos, DMV, MS,
Prabhu P Raju,
Rachael A Moliver,
Rachael O Oyewole,
Roseline N Boateng,
Satheesh Thomas,
Sena G Dissmeyer,
Sony Mathews,
Stephanie Mangigian, MS/OSH, RN,
Susan F Laska, MS,
Tammy L Chavis,
Tania E Vizcaino,
Tanya R Syffrard,
Thomas E Friel,
Vlada Matusovsky,
William J Leonard,
Yiyue Zhang (nmi), PhD,
Yvonne C Mcknight,
Zhao Wang, PhD,
Zhong Li, PhD
Tekalign Wondimu's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2023 | FDA 483 | Pine Pharmaceuticals, LLC - Form 483, 2023-09-19 |
October, 2021 | EIR | Frontage Laboratories, Inc. - EIR, 2021-10-15 |
June, 2021 | FDA 483 | Granules Pharmaceuticals Inc. - Form 483, 2021-06-25 |
August, 2022 | FDA 483 | ImprimisRx NJ - Form 483, 2022-08-05 |
October, 2021 | FDA 483 Response | Frontage Laboratories, Inc. - Form 483R, 2021-11-04 |
June, 2022 | FDA 483 | Dercher Enterprises, Inc., DBA Gordon Laboratories - Form 483, 2022-06-13 |
May, 2023 | FDA 483 | West Services and Solutions LLC - Form 483, 2023-05-18 |
October, 2021 | FDA 483 | Frontage Laboratories, Inc. - Form 483, 2021-10-15 |
March, 2022 | FDA 483 | Elementis SRL, Inc. - Form 483, 2022-03-17 |
December, 2023 | FDA 483 | Granules Pharmaceuticals Inc. - Form 483, 2023-12-15 |
July, 2023 | FDA 483 | Sentara Enterprises dba Sentara Infusion Services (Blue Ridge) - Form 483, 2023-07-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more